RS Bio ApS Financials, key figures and credit report
Gross profit -93.8 kDKK FY 2025 +73.3% vs 2024
EBIT -93.8 kDKK FY 2025 +73.3% vs 2024
Net debt 1 370.2 kDKK FY 2025 -97% vs 2024
Quick ratio 64.9 FY 2025 +55.8 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | - 289.38 | - 267.60 | - 176.40 | - 351.03 | -93.83 |
| EBIT | - 289.38 | - 267.60 | - 176.40 | - 351.03 | -93.83 |
| Other financial income | 2 100.29 | 2 275.03 | 4 469.57 | 32 316.42 | 24 108.06 |
| Other financial expenses | -2.66 | -15.36 | - 735.56 | -1 771.02 | 108.74 |
| Net income from associates (fin.) | 288 691.63 | - 391 879.60 | 221 248.49 | 9 822.17 | |
| Pre-tax profit | 290 499.88 | - 389 887.52 | 224 806.11 | 40 016.54 | 24 122.96 |
| Income taxes | - 397.80 | - 438.78 | - 782.67 | -6 642.74 | -5 307.51 |
| Net earnings | 290 102.08 | - 390 326.31 | 224 023.43 | 33 373.80 | 18 815.45 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Participating interests | 461 314.55 | 69 434.96 | 312 067.07 | ||
| Investments total | 461 314.55 | 69 434.96 | 312 067.08 | ||
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 461 278.65 | 435 152.72 | |||
| Current other receivables | 38 675.00 | 40 950.00 | 52 018.88 | 11 328.58 | 11 333.64 |
| Short term receivables total | 38 675.00 | 40 950.00 | 52 018.88 | 472 607.24 | 446 486.36 |
| Cash and bank deposits | 282.19 | 85.04 | 772.29 | 168.41 | 62.27 |
| Cash and cash equivalents | 282.19 | 85.04 | 772.29 | 168.41 | 62.27 |
| Balance sheet total (assets) | 500 271.74 | 110 470.00 | 364 858.24 | 472 775.65 | 446 548.64 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 76.00 | 76.00 | 76.00 | 76.00 | 76.00 |
| Retained earnings | 209 393.85 | 499 495.93 | 109 169.63 | 387 405.96 | 420 779.75 |
| Profit of the financial year | 290 102.08 | - 390 326.31 | 224 023.43 | 33 373.80 | 18 815.45 |
| Shareholders equity total | 499 571.93 | 109 245.63 | 333 269.06 | 420 855.76 | 439 671.21 |
| Non-current liabilities total | |||||
| Current trade creditors | 70.00 | 142.00 | 62.50 | 100.00 | 137.50 |
| Current owed to group member | 232.17 | 643.69 | 30 744.01 | 45 782.19 | 1 432.44 |
| Short-term deferred tax liabilities | 397.63 | 438.68 | 782.67 | 6 037.70 | 5 307.49 |
| Current liabilities total | 699.80 | 1 224.37 | 31 589.18 | 51 919.89 | 6 877.43 |
| Balance sheet total (liabilities) | 500 271.74 | 110 470.00 | 364 858.24 | 472 775.65 | 446 548.64 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated